Case Details
- Citation: [2016] SGHC 21
- Case Title: Hii Chii Kok v Ooi Peng Jin London Lucien and another
- Court: High Court of the Republic of Singapore
- Decision Date: 22 February 2016
- Case Number: Suit No 806 of 2012
- Judge: Chan Seng Onn J
- Tribunal/Coram: High Court; Coram: Chan Seng Onn J
- Plaintiff/Applicant: Hii Chii Kok
- Defendants/Respondents: Ooi Peng Jin London Lucien and another
- Second Defendant (as described in the judgment): National Cancer Centre of Singapore Pte Ltd (“NCCS”)
- First Defendant (as described in the judgment): Professor Ooi Peng Jin London Lucien (“Prof Ooi”)
- Legal Areas: Tort – Negligence – Breach of duty; Tort – Negligence – Causation
- Statutes Referenced: None stated in the provided extract
- Counsel for Plaintiff: Palaniappan Sundararaj and Lim Min (Straits Law Practice LLC)
- Counsel for First Defendant: Edwin Tong SC, Mak Wei Munn, Tham Hsu Hsien, Christine Tee and Hoh Jian Yong (Allen & Gledhill LLP)
- Counsel for Second Defendant: Kuah Boon Theng, Felicia Chain, Gerald Soo and Karen Yong (Legal Clinic LLC)
- Appeal Note (LawNet Editorial Note): The appeal to this decision in Civil Appeal No 33 of 2016 was dismissed by the Court of Appeal on 12 May 2017. See [2017] SGCA 38.
- Judgment Length: 64 pages; 35,339 words
Summary
This High Court decision concerns a claim in medical negligence arising from pancreatic surgery performed after a multidisciplinary diagnostic process at the National Cancer Centre of Singapore (“NCCS”). The plaintiff, Dato’ Seri Hii Chii Kok, had a history of a neuroendocrine tumour (“NET”) in his lung. Following a Gallium PET/CT scan that showed high tracer uptake in two pancreatic areas (the pancreatic body and the uncinate process), the NCCS tumour board and the treating surgeon, Prof Ooi, diagnosed pancreatic neuroendocrine tumours (“PNETs”) but also considered a differential diagnosis of a rarer condition—pancreatic polypeptide hyperplasia (“hyperplasia”). The plaintiff ultimately underwent a Whipple procedure and a resection, but post-operative histopathology revealed hyperplasia rather than PNETs.
The plaintiff sued Prof Ooi and the NCCS for negligence in relation to (i) the diagnoses and (ii) advice and post-operative management. Applying Singapore’s established medical negligence framework—derived from Khoo James v Gunapathy and the Bolam–Bolitho test—the court held that the defendants were not negligent. Even if the court were to analyse the case using the more patient-centric “informed consent” approach associated with Montgomery v Lanarkshire Health Board, the court found that the defendants had still not fallen below the required standard of care.
What Were the Facts of This Case?
The plaintiff is a Malaysian businessman with a law degree and experience as an English language journalist. He had a complex medical history spanning several years, including surgeries and consultations in Malaysia for conditions affecting his lungs, thyroid, and prostate. In 2000, he underwent surgery for hyperthyroidism. In 2003, lung nodules were discovered. By 2010, the lung nodule had enlarged, and histopathology from a computed tomography-guided biopsy identified the lung nodule as a NET of low grade malignancy.
In July 2010, the plaintiff consulted a medical oncologist in Malaysia, Dr Foo Yoke Ching (“Dr Foo YC”), about treatment for the lung NET. Dr Foo YC considered it advisable for the plaintiff to undergo further investigation in Singapore and referred him to the NCCS. The referral was motivated by the plaintiff’s interest in surgery in Singapore and the need to clarify the extent and nature of disease.
At the SGH/NCCS setting, the plaintiff underwent a Gallium PET/CT scan using a Gallium-68 tagged DOTATATE tracer. The scan showed very minimal tracer uptake in the right lung nodule, but it also revealed focal areas of increased tracer uptake in the pancreatic uncinate process (SUVmax 23.0) and the pancreatic body (SUVmax 13.2), without a definite corresponding mass on imaging. The scan also showed mildly increased tracer uptake in the thyroid parenchyma, which could be secondary to hyperplasia. Importantly, the pancreatic findings raised clinical suspicion for PNETs, but the absence of a definite mass meant that imaging alone could not conclusively distinguish PNETs from other conditions.
Following the Gallium PET/CT findings, the plaintiff was advised to undergo further imaging. The next day, he underwent an MRI scan, which revealed no mass in the pancreatic lesions. The case was then discussed by a tumour board comprising a multidisciplinary team with relevant sub-specialty expertise. The tumour board considered both the clinical diagnosis (PNETs in two pancreatic locations) and a differential diagnosis (pancreatic polypeptide hyperplasia), recognising that hyperplasia was rare but less serious. The consensus among experts at trial was that the most definitive method to differentiate between PNETs and hyperplasia was post-operative histopathology, and that no pre-operative diagnostic tool or investigative procedure could reliably make the distinction.
What Were the Key Legal Issues?
The central legal issues were whether the defendants breached the standard of care in (a) diagnosing the plaintiff’s condition and (b) advising him about treatment options and risks, and whether any such breach caused the plaintiff’s loss. The plaintiff’s complaint was not merely that the final histopathology differed from the pre-operative working diagnosis; rather, it was that the defendants should have reached a different conclusion or provided different advice.
A further issue concerned the applicable legal test for medical negligence in Singapore, particularly for the “advice” component. The court had to consider whether the Bolam–Bolitho test (as applied in Khoo James v Gunapathy) governs negligence in relation to medical advice, or whether the doctrine of informed consent—developed in other jurisdictions and associated with Montgomery—should apply instead. The plaintiff’s case effectively invited the court to assess negligence in advice through a patient-centric lens focused on disclosure of material risks and alternatives.
How Did the Court Analyse the Issues?
Chan Seng Onn J began by situating the case within Singapore’s medical negligence jurisprudence. The court reiterated that the law on medical negligence is set out in Khoo James v Gunapathy, which requires application of the Bolam–Bolitho test. Under that framework, the question is whether the doctor’s conduct accords with a practice accepted as proper by a responsible body of medical professionals skilled in that particular art, subject to the Bolitho qualification that the professional opinion must be logically defensible.
The court emphasised that the Bolam–Bolitho test applies clearly to questions of diagnosis and treatment. The judgment also addressed arguments that informed consent should apply to the question of whether a doctor was negligent in advising a patient about material risks and alternative treatment options. The judge noted that, in earlier High Court decisions, the High Court had observed that it was bound by Khoo James to apply the Bolam–Bolitho test in relation to medical advice. The judge adopted a similar view, explaining that Singapore law currently follows the Bolam–Bolitho approach for medical advice as well.
Although the court acknowledged that English law has moved away from Bolam–Bolitho towards an informed consent doctrine in Montgomery, it did not treat Montgomery as automatically determinative for Singapore. The judgment canvassed the policy rationale for the shift away from medical paternalism and towards patient autonomy, but concluded that it remained “to be decided” whether Singapore should follow Montgomery. In the present case, the court held that it was bound to apply Bolam–Bolitho, while also stating that even if Montgomery were applied, the defendants would still not be negligent.
On the merits, the court found that the defendants were not negligent in reaching the diagnoses. The reasoning turned on the clinical context and the limits of pre-operative diagnostics. The tumour board and the treating surgeon had identified both the clinical diagnosis (PNETs) and the differential diagnosis (hyperplasia). The court accepted the expert consensus that post-operative histopathology was the definitive method to distinguish PNETs from hyperplasia and that no pre-operative tool could reliably do so. In negligence law, the standard is not perfection or hindsight accuracy; it is whether the defendants exercised reasonable care consistent with responsible professional practice. Given the imaging findings (high tracer uptake in two pancreatic areas without a definite mass) and the rarity of hyperplasia, the court treated the diagnostic process as one that fell within the range of acceptable medical judgment.
Turning to advice and post-operative management, the court held that the plaintiff had been informed of both the clinical diagnosis and the differential diagnosis, as well as the options flowing from those possibilities. The NCCS highlighted that the plaintiff could either wait for six months or proceed with surgical resection of the pancreatic lesions. The plaintiff consulted Prof Ooi to ascertain surgical feasibility, and Prof Ooi determined that the lesions could be removed via a Whipple procedure for the uncinate process and a surgical resection for the pancreatic body. The plaintiff chose “aggressive treatment” and proceeded with surgery. The court found no negligence in the advice rendered or in the post-operative management.
Crucially, the court’s analysis of causation and breach was anchored in the absence of a proven departure from the standard of care. The fact that the post-operative histopathology ultimately showed hyperplasia rather than PNETs did not, by itself, establish negligence. The court’s approach reflects a consistent theme in medical negligence cases: diagnostic uncertainty is often inherent in medicine, and liability requires proof that the doctor’s conduct fell below the required standard, not merely that the outcome was different from the working diagnosis.
Even under a Montgomery-style informed consent analysis, the court found that the defendants had taken reasonable care to ensure that the plaintiff was aware of material risks and reasonable alternatives. This conclusion was supported by the record that the plaintiff was told about the differential diagnosis and the option of waiting, and that the surgical plan and its basis were explained. The court therefore rejected the plaintiff’s attempt to reframe the negligence claim as a failure of disclosure that would trigger liability under a patient-centric standard.
What Was the Outcome?
The High Court dismissed the plaintiff’s claim. Chan Seng Onn J held that the defendants were not negligent in reaching the diagnoses, not negligent in the advice rendered to the plaintiff, and not negligent in the post-operative management of the plaintiff. The court’s findings meant that the plaintiff failed to establish breach of duty, and consequently the negligence claim could not succeed.
As noted in the LawNet editorial note, the plaintiff’s appeal was dismissed by the Court of Appeal on 12 May 2017 in Civil Appeal No 33 of 2016, reported as [2017] SGCA 38. The appellate outcome reinforces the High Court’s application of the Bolam–Bolitho framework and its conclusion that the defendants’ conduct met the required standard of care.
Why Does This Case Matter?
This case is significant for practitioners because it clarifies how Singapore courts approach medical negligence claims involving diagnostic uncertainty and informed consent arguments. First, it confirms that, at least as of 2016, Singapore law remains anchored in the Bolam–Bolitho test for medical advice as well as diagnosis and treatment, following Khoo James v Gunapathy. The judgment also shows that courts will consider Montgomery only as a comparative or alternative analytical framework, rather than displacing Singapore’s binding precedent.
Second, the decision illustrates how courts evaluate the reasonableness of clinical judgment when definitive pre-operative differentiation is not available. The court’s reliance on expert consensus that histopathology was the definitive differentiator underscores that negligence is assessed against what responsible medical professionals would do in the circumstances, not against the eventual histological outcome. For litigators, this is a useful reminder that “wrong diagnosis” is not synonymous with “negligence” where the medical evidence supports a reasonable working diagnosis and the alternative explanation is rare or cannot be reliably excluded pre-operatively.
Third, the case provides practical guidance on informed consent in Singapore medical negligence litigation. Even though the court did not adopt Montgomery as the governing test, it still examined whether the plaintiff was informed of material matters, including the differential diagnosis and treatment alternatives. This suggests that, in practice, good documentation and clear communication about uncertainty and options will be central to defending negligence claims, regardless of whether the court ultimately applies Bolam–Bolitho or an informed consent lens.
Legislation Referenced
- No specific statute is identified in the provided judgment extract.
Cases Cited
- [2011] SGHC 193
- [2016] SGHC 21
- [2017] SGCA 38
- Khoo James and another v Gunapathy d/o Muniandy and another appeal [2002] 1 SLR(R) 1024
- Bolam v Friern Hospital Management Committee [1957] 1 WLR 582
- Bolitho v City and Hackney Health Authority [1998] AC 232
- Montgomery v Lanarkshire Health Board (General Medical Council intervening) [2015] AC 1430
- Surender Singh s/o Jagdish Singh and another (administrators of the estate of Narindar Kaur d/o Sarwan Singh, deceased) v Li Man Kay and others [2010] 1 SLR 428
- D’Conceicao Jeanie Doris (administratrix of the estate of Milakov Steven, deceased) v Tong Ming Chuan [2011] SGHC 193
- Tong Seok May Joanne v Yau Hok Man Gordon [2013] 2 SLR 18
Source Documents
This article analyses [2016] SGHC 21 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.